Product Launch (Blog)

Jul, 19 2023

Controlling Bacterial Infections and Diseases in Animals


The disease treatment and prevention aspect of animal antibiotics antimicrobials is a significant driver in the animal antibiotics antimicrobials. These antimicrobials are vital in controlling and managing animal bacterial infections and diseases. They offer treatment options for existing infections while also acting as a preventive measure to prevent the spread of diseases among animal populations. The increasing prevalence of animal diseases and the growing awareness of the importance of disease management and prevention fuels the demand for these antimicrobials. This drives market growth, as veterinary healthcare professionals and pet owners rely on effective and reliable solutions to ensure the health and well-being of animals.

According to Data Bridge Market Research, the Global Animal Antibiotics Antimicrobials Market accounted for USD 4.5 billion in 2021 and is expected to reach USD 6.3 billion by 2029, registering a CAGR of 4.10% during the forecast period of 2022-2029.

“Increasing concerns regarding animal health upsurge the market”

The rising concerns surrounding animal health have resulted in increased spending on animal healthcare and a surge in demand for pet insurance. This has led to a substantial increase in the demand for animal antibiotics and antimicrobials, propelling the market growth. Furthermore, initiatives dedicated to improving animal health and welfare and a growing prevalence of zoonotic diseases are anticipated to expand the market. These factors play a pivotal role in fostering the overall growth and advancement of the animal antibiotics and antimicrobials market.

What restraints the growth of global animal antibiotics antimicrobials market?

“Higher in costs of animal antibiotics antimicrobials hampers the market”

Increased costs associated with the development, manufacturing, and regulatory compliance of animal antibiotics and antimicrobials act as a significant restraint in the market. These costs include research and development expenses, clinical trials, production, and regulatory fees. Higher costs often translate into elevated prices for veterinary medicines, making them less accessible to farmers and livestock owners. Limited affordability can hinder the adoption of antibiotics and antimicrobials, potentially leading to inadequate disease prevention and treatment measures in animals, thereby impacting the growth and effectiveness of the animal antibiotics antimicrobials market.

Segmentation: Animal Antibiotics Antimicrobials Market

The animal antibiotics antimicrobials market is segmented on the basis of product, mode of delivery and animal type. 

  • On the basis of product, the animal antibiotics antimicrobials market is segmented into Tetracycline, penicillin, sulfonamide, macrolide, cephalosporin, fluoroquinolone, lincosamides, cephalosporins.
  • On the basis of mode of delivery, the animal antibiotics antimicrobials market is segmented into premixes, oral powder, injection, others.
  • On the basis of animal type, the animal antibiotics antimicrobials market is segmented into food-producing animals, companion animals.

Regional Insights: North America Dominates the Global Animal Antibiotics Antimicrobials Market

The dominance of North America in the animal antibiotics antimicrobials market can be attributed to factors such as high ownership of companion animals, rising instances of animal diseases, and substantial investments in the development of drugs for animal-related ailments in the region.

During the forecast period of 2022 to 2029, Asia-Pacific is projected to experience notable growth in the animal antibiotics antimicrobials market. This growth can be attributed to increased government initiatives to address animal disease outbreaks, a rising livestock population, and growing demand for animal antimicrobials in the region.

To know more about the study visit,

Recent Developments in Global Animal Antibiotics Antimicrobials Market

  • In July 2020, a collaboration was established between Trianni Inc. (US) and Zoetis (US) to jointly develop transgenic monoclonal antibody platforms for the discovery of innovative veterinary medicines. Additionally, the US Food and Drug Administration (FDA) granted authorization to Zoetis (US) for the acquisition of Marboquin, expanding their portfolio of veterinary products.

The Prominent Key Players Operating in the Global Animal Antibiotics Antimicrobials Market Include:

  • Boehringer Ingelheim International GmbH (Germany)
  • Zoetis (U.S.)
  • Elanco (U.S.)
  • Merck & Co. Inc. (U.S.)
  •  Phibro Animal Health Corporation (U.S.)
  •  Virbac (France)
  • Vetoquinol (France)
  • HIPRA (Spain)
  •  Ceva (France)
  •  Dechra (U.K.)
  •  Kyoritsuseiyaku Corporation (Japan)
  •  Endovac Animal Health (U.S.)
  •  Zydus Group (India)
  • Indian Immunologicals Pvt. Ltd. (India)
  • UCBVET Saúde e Bem Estar Animal (U.S.)
  • American Reagent Inc. (U.S.)
  •  Neogen Corporation (U.S.)
  •  Huvepharma (U.S.)
  •  Ayurvet (India)
  • Ashish Life Science (India)
  • Inovet Group (Belgium)
  • Lutim Pharma Private Limited  (India)
  • ECO Animal Health Ltd (U.S.)

Above are the key players covered in the report, to know about more and exhaustive list of global animal antibiotics antimicrobials market companies contact,

Research Methodology: Global Animal Antibiotics Antimicrobials Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


Client Testimonials